Moreover, combining both D-dimer and albumin, known as the albumin to D-dimer ratio (ADR), may reflect the inflammation, nutrition, and coagulation function of cancer patients at the same time, thereby improving the predictive accuracy for GC patient prognostication as compared to albumin and D-dimer alone. This evidence concerns the gene ALB and cancer.